| Sources | Names Used |
|---|---|
| CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
| PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD55 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | C15orf65 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | NACAD | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | MYO10 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | C5orf38 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | KCNRG | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CT45A8 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CYP4A11 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | GPR135 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | LAMC1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
